Chronic social stress disrupts the intracellular redistribution of brain hexokinase 3 induced by shifts in peripheral glucose levels.


Journal

Journal of molecular medicine (Berlin, Germany)
ISSN: 1432-1440
Titre abrégé: J Mol Med (Berl)
Pays: Germany
ID NLM: 9504370

Informations de publication

Date de publication:
10 2022
Historique:
received: 01 02 2022
accepted: 04 07 2022
revised: 06 06 2022
pubmed: 10 8 2022
medline: 16 9 2022
entrez: 9 8 2022
Statut: ppublish

Résumé

Chronic stress has the potential to impair health and may increase the vulnerability for psychiatric disorders. Emerging evidence suggests that specific neurometabolic dysfunctions play a role herein. In mice, chronic social defeat (CSD) stress reduces cerebral glucose uptake despite hyperglycemia. We hypothesized that this metabolic decoupling would be reflected by changes in contact sites between mitochondria and the endoplasmic reticulum, important intracellular nutrient sensors, and signaling hubs. We thus analyzed the proteome of their biochemical counterparts, mitochondria-associated membranes (MAMs) from whole brain tissue obtained from CSD and control mice. This revealed a lack of the glucose-metabolizing enzyme hexokinase 3 (HK3) in MAMs from CSD mice. In controls, HK3 protein abundance in MAMs and also in striatal synaptosomes correlated positively with peripheral blood glucose levels, but this connection was lost in CSD. We conclude that the ability of HK3 to traffic to sites of need, such as MAMs or synapses, is abolished upon CSD and surmise that this contributes to a cellular dysfunction instigated by chronic stress. KEY MESSAGES : Chronic social defeat (CSD) alters brain glucose metabolism CSD depletes hexokinase 3 (HK3) from mitochondria-associated membranes (MAMs) CSD results in loss of positive correlation between blood glucose and HK3 in MAMs and synaptosomes.

Identifiants

pubmed: 35943566
doi: 10.1007/s00109-022-02235-x
pii: 10.1007/s00109-022-02235-x
pmc: PMC9470722
doi:

Substances chimiques

Blood Glucose 0
Hexokinase EC 2.7.1.1
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1441-1453

Informations de copyright

© 2022. The Author(s).

Références

J Biol Chem. 1994 Nov 4;269(44):27494-502
pubmed: 7961664
Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10187-E10196
pubmed: 30301805
Transl Psychiatry. 2020 Jun 1;10(1):176
pubmed: 32488052
J Proteome Res. 2017 Nov 3;16(11):4060-4072
pubmed: 28948796
Front Neurosci. 2017 Dec 19;11:716
pubmed: 29311793
Mol Cell Biol. 2008 Feb;28(3):1007-17
pubmed: 18039843
J Neurobiol. 2006 May;66(6):522-36
pubmed: 16555236
J Psychiatr Res. 2009 Jun;43(9):864-9
pubmed: 19100996
J Cell Sci. 2006 Apr 15;119(Pt 8):1494-503
pubmed: 16537643
Psychoneuroendocrinology. 2021 Oct;132:105346
pubmed: 34274734
Psychoneuroendocrinology. 2012 Jul;37(7):1057-70
pubmed: 22244747
Nature. 2008 Dec 4;456(7222):605-10
pubmed: 19052620
J Membr Biol. 1987;99(1):65-72
pubmed: 2448471
Curr Biol. 2017 Feb 6;27(3):371-385
pubmed: 28132811
Front Behav Neurosci. 2018 Jul 10;12:134
pubmed: 30057529
Nat Med. 2014 Dec;20(12):1427-35
pubmed: 25419710
Genetics. 2005 Oct;171(2):783-90
pubmed: 15956674
Cell Rep. 2021 Mar 16;34(11):108873
pubmed: 33730569
Trends Endocrinol Metab. 2017 Jan;28(1):32-45
pubmed: 27670636
J Endocrinol. 2021 Apr;249(1):19-30
pubmed: 33608492
Neurology. 2010 Sep 14;75(11):997-1002
pubmed: 20837967
Nat Rev Endocrinol. 2014 May;10(5):303-10
pubmed: 24663223
Antioxid Redox Signal. 2013 Apr 20;18(12):1475-90
pubmed: 22746161
Psychoneuroendocrinology. 2018 May;91:149-158
pubmed: 29555365
Front Neuroendocrinol. 2018 Apr;49:72-85
pubmed: 29339091
Cell Death Differ. 2016 Sep 1;23(9):1417-27
pubmed: 27341186
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5523-8
pubmed: 22427360
Cell. 2007 Oct 19;131(2):391-404
pubmed: 17956738
Nat Protoc. 2009;4(11):1582-90
pubmed: 19816421
J Cell Sci. 2015 Aug 1;128(15):2781-94
pubmed: 26101353
J Biol Chem. 2011 Jun 10;286(23):20423-30
pubmed: 21502324
Cell Metab. 2012 Dec 5;16(6):706-22
pubmed: 23168220
Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1958;196(6):611-26
pubmed: 13534602
Nat Rev Neurosci. 2009 Jun;10(6):434-45
pubmed: 19401723
Br J Pharmacol. 2014 Apr;171(8):2147-58
pubmed: 24319993
Nat Protoc. 2016 Apr;11(4):795-812
pubmed: 27010757
Cell. 2013 Sep 26;155(1):172-87
pubmed: 24074867
PLoS One. 2010 Nov 03;5(11):e13823
pubmed: 21072205
Cell. 2013 Sep 26;155(1):188-99
pubmed: 24074868
Mol Cell Neurosci. 2020 Sep;107:103525
pubmed: 32629109
J Cell Biol. 2006 Dec 18;175(6):901-11
pubmed: 17178908
J Bioenerg Biomembr. 2007 Jun;39(3):211-22
pubmed: 17879147
Methods Mol Biol. 2017;1567:53-68
pubmed: 28276013
Genomics. 1994 Nov 15;24(2):280-7
pubmed: 7698750
Neurochem Int. 2009 May-Jun;54(5-6):358-62
pubmed: 19171172
J Diabetes Res. 2014;2014:137919
pubmed: 25019091
Ann N Y Acad Sci. 2004 Dec;1032:1-7
pubmed: 15677391
Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16017-22
pubmed: 25352671
Cell Rep. 2016 Apr 5;15(1):219-220
pubmed: 27050774

Auteurs

Michael A van der Kooij (MA)

Leibniz Institute for Resilience Research (LIR), Mainz, 55122, Germany. michael.vanderkooij@lir-mainz.de.

Liliana Rojas-Charry (L)

Institute for Molecular Medicine, Johannes Gutenberg University Mainz, Mainz, 55131, Germany.
Institute of Anatomy, Johannes Gutenberg University Mainz, Mainz, 55131, Germany.

Maryam Givehchi (M)

Leibniz Institute for Resilience Research (LIR), Mainz, 55122, Germany.

Christina Wolf (C)

Institute for Molecular Medicine, Johannes Gutenberg University Mainz, Mainz, 55131, Germany.

Diones Bueno (D)

Institute for Molecular Medicine, Johannes Gutenberg University Mainz, Mainz, 55131, Germany.

Sabine Arndt (S)

Institute for Immunology, Johannes Gutenberg University Mainz, Mainz, 55131, Germany.

Stefan Tenzer (S)

Institute for Immunology, Johannes Gutenberg University Mainz, Mainz, 55131, Germany.

Lorenzo Mattioni (L)

Institute of Anatomy, Johannes Gutenberg University Mainz, Mainz, 55131, Germany.

Giulia Treccani (G)

Institute of Anatomy, Johannes Gutenberg University Mainz, Mainz, 55131, Germany.
Department of Psychiatry and Psychotherapy, Translational Psychiatry, University Medical Center, Johannes Gutenberg University Mainz, Mainz, 55131, Germany.

Annika Hasch (A)

Leibniz Institute for Resilience Research (LIR), Mainz, 55122, Germany.

Michael J Schmeisser (MJ)

Institute of Anatomy, Johannes Gutenberg University Mainz, Mainz, 55131, Germany.

Caterina Vianello (C)

Institute for Molecular Medicine, Johannes Gutenberg University Mainz, Mainz, 55131, Germany.
Department of Biology, University of Padua, Padua, 35121, Italy.

Marta Giacomello (M)

Department of Biology, University of Padua, Padua, 35121, Italy.

Axel Methner (A)

Institute for Molecular Medicine, Johannes Gutenberg University Mainz, Mainz, 55131, Germany. axel.methner@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH